Acurx Pharmaceuticals, Inc. Share Price
ACXPAcurx Pharmaceuticals, Inc. Stock Performance
Open $2.01 | Prev. Close $2.01 | Circuit Range N/A |
Day Range $1.97 - $2.01 | Year Range $1.37 - $21.00 | Volume 1,274 |
Average Traded $1.99 |
Acurx Pharmaceuticals, Inc. Share Price Chart
About Acurx Pharmaceuticals, Inc.
Acurx Pharmaceuticals, Inc., a clinical stage biopharmaceutical company, develops antibiotics to treat bacterial infections in the United States. The company's lead antibiotic candidate is ibezapolstat, a novel mechanism of action that targets the polymerase IIIC enzyme that is in Phase 2b clinical trial to treat patients with clostridium difficile infections. It also develops ACX-375C, a potential oral and parenteral treatment targeting gram-positive bacteria, including methicillin-resistant staphylococcus aureus, vancomycin-resistant enterococcus, and penicillin-resistant streptococcus pneumonia; and CCP, multiple product candidates for gram-positive infections. Acurx Pharmaceuticals, Inc. was incorporated in 2017 and is headquartered in Staten Island, New York.
Acurx Pharmaceuticals, Inc. Historical Data
| Day | Open | Close | Change % |
|---|---|---|---|
28-Apr-26 | $2.04 | $2.01 | -0.99% |
27-Apr-26 | $1.98 | $2.03 | +1.96% |
24-Apr-26 | $2.07 | $1.99 | +0.00% |
23-Apr-26 | $2.15 | $1.99 | -9.95% |
22-Apr-26 | $2.28 | $2.21 | -3.49% |
21-Apr-26 | $2.35 | $2.29 | -2.14% |
20-Apr-26 | $2.28 | $2.34 | -0.64% |